The Future for Psychedelic Agents in the Treatment of Posttraumatic Stress Disorder
The Journal for Nurse Practitioners
; 19(5), 2023.
Article
in English
| ProQuest Central | ID: covidwho-2315262
ABSTRACT
Posttraumatic stress disorder (PTSD) treatment options, including the potential use of psychedelic-assisted therapy, are reviewed. Traditional PTSD treatment remains ineffective for many, and includes, trauma focused cognitive behavioral therapy, eye movement desensitization and remodeling, and selective serotonin reuptake inhibitors. Evidence has shown that with further supportive research, psychedelic-assisted therapy may offer an alternative treatment option.
Medical Sciences--Nurses And Nursing; MDMA; post-traumatic stress disorder; psilocybin; psychedelics; PTSD; trauma; Comorbidity; Desensitization; Eye movement desensitization; Serotonin reuptake inhibitors; Cognitive-Behavioural factors; Traditional medicine; Alternative medicine; Cognitive behavioral therapy; Coronaviruses; Post traumatic stress disorder; COVID-19; United States--US
Full text:
Available
Collection:
Databases of international organizations
Database:
ProQuest Central
Language:
English
Journal:
The Journal for Nurse Practitioners
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS